Learn more about the new chronic myeloid leukemia (CML) program in Lesotho! In 2025, we partnered with local healthcare professionals to provide access to diagnostics, medication, and support services. The first patient began receiving treatment in December.
Africa Region Head Cathy Scheepers will introduce you to Dr. Kabelo Mputsoe, the first oncologist in the country. She was born and raised in Lesotho and has spent the last several years building up the clinic and caring for residents living with cancer. It’s her goal to bring treatment home.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries, including Sierra Leone and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Setu Kumari Khadka was born in Nepal in 1989 to much celebration, as the first daughter born into her family after several generations. Setu remembers being weak and having health issues as a child and having to be taken to Mumbai, India for diagnosis and hospitalized there. No cause for her weakness came out of….
Finding effective treatment is difficult for people living with cancer in low- and middle-income countries. It can take years to start feeling better. Christian, called Tian by his loved ones, works as a medical technologist at a private hospital in the Philippines. He was diagnosed with chronic myeloid leukemia (CML) in 2012, when he was….
A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.
